Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06125054 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ketamine and Neurofeedback-Training: Effects on Neuroplasticity in Cocaine Addiction

Study acronym: Co-Boost
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 20, 2024 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Secondary endpoints: 17 to 16
    • Site details revised
    v5
  2. Minor Start date changed from estimate of Jan 2024 to Feb 5, 2024v4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date: Dec 2023 to Jan 2024
    • Site details revised
    v3
  4. Minor Re-verified, no change to tracked fieldsv2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to learn about the effects of the combination of ketamine and realtime functional magnetic resonance imaging (fMRI) neurofeedback training in individuals with cocaine use disorder. The main questions the investigators aim to answer are: * Can the investigators observe a positive, significant effect on percentage of cocaine use days of both interventions combined as well as stand alone interventions? * Is there a significant transfer effect of the neurofeedback training? * Is there a significant, ketamine-dependent change in glutamate levels in the nucleus accumbens? Participants will be given ketamine and a realtime fMRI neurofeedback training. Both interventions are placebo-controlled. The investigators will compare the four intervention groups to investigate the effects of the stand-alone effects of the intervention and the combination of it.
Trial Details
NCT Number NCT06125054
Lead Sponsor Dr. med. Marcus Herdener
Collaborators: University of Zurich, University of Vienna, University of Campania Luigi Vanvitelli
Conditions
(from sponsor)
Cocaine Use Disorder, Cocaine Dependence
Related terms Cocaine-Related Disorders
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov